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being the most cost-effective treatment compared with atypical,
oral and depot typical antipsychotic medications.
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OBJECTIVES: To investigate whether patients with bipolar dis-
order (BD) who are misdiagnosed with major depressive disor-
der (MDD) can be identiﬁed through claims data-based predictor
variables. METHODS: Administrative claims data from 3 US
health plans were used to identify patients diagnosed with MDD
between January 1, 2000 through March 31, 2004. An age-,
gender-, and region-stratiﬁed random sample of patients with
°Ã2 medical claims for MDD and none for BD was surveyed 
via telephone to complete the Mood Disorder Questionnaire
(MDQ), a tool used to screen patients for BD symptoms. Uni-
variate logistic regression, followed by multivariate techniques,
was used to identify predictors of BD. Baseline variables with a
univariate p-value <0.10 were entered into the ¢®°Æbest-ﬁt¢®±
multivariable model with acceptable predictive validity for ﬁnal
predictor variable selection. RESULTS: From a sampling frame
of 41,738 patients diagnosed with MDD, based on sample size
calculations, surveys were administered until a target sample of
1360 patients was screened. Screened BD positive patients (n =
94, 6.9%) were considered likely to be inaccurately diagnosed.
A higher percentage of males screened positive compared to
females (8.6% vs 6.1% respectively, P = 0.092) and patients aged
18–35 were 3 times more likely to screen positive than patients
56 years and above (P < 0.01). Rates of inpatient or ER visits
related to mental health conditions were higher in patients
screening positive compared to patients screening negative for
BD (40.4% vs 21.3%, P < 0.01). The ﬁnal model indicated that
age, gender, rate of inpatient or ER visits related to mental health
conditions, substance abuse, concomitant use of anticonvulsants,
antidepressants, antipsychotic medications, and anxiolytic
agents are useful predictors in identifying BD patients who are
diagnosed inaccurately with MDD. CONCLUSION: These
claims data-based predictor variables, after necessary validation
and reliability checks, can be used by health plans in identifying
patients at high risk of missed BD diagnosis.
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OBJECTIVES: To examine whether perceived access to illicit
drugs by occupation is consistent with acutual drug use.
METHODS: We used data from a 2003 National Survey on
Drug Use and Health. A total of 55,245 Americans aged 12 and
older participated in the study. Of those 55,245 study partici-
pants, 29,915 subjects who are currently employed were selected
for this present study. Descriptive analyese (ANOVA and chi-
square test) and regression modeling were performed to detect
the difference between illict drug use and occupation. RESULTS:
The majority of the sample was white (70%) and half of the
sample was male (56%). About 44% of the sample was between
the ages of 18 and 25. Of the 5 illicit drugs, marijuana was found
to be easiest to access, followed by cocaine, crack, LSD, and
heroin. Protective service workers reported having the easiest
access to all ﬁve substances, followed by sales occupations. Com-
pared to other occupations, workers in entertainment, sports,
media, and communications reported having relatively easy
access to marijuana and LSD. Protective service workers were
the best predictor of easy access to all ﬁve illict drugs. CON-
CLUSION: Inconsistency was found that protective service
workers had an easy access to drugs but their actual usage of
illicit drugs was very low. Other policy implications relating to
access to drugs by occupations were addressed in the study.
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OBJECTIVES: We analyzed prescribing patterns for ADD treat-
ment among children of Arkansas state employees and public
school employees (primarily elementary and secondary teachers)
in order to determine if differences existed based on age, gen-
der, type of stimulant prescribed, and medication dosage.
METHODS: This observational study utilized administrative
claims from a state employees’ database in 2005. The popula-
tion consisted of children (less than 19 years) with a diagnosis
of ADD with or without hyperactivity. RESULTS: 1100 children
(3.6%) in the claims database (30,821 children 3 to 18 years)
had a diagnosis of ADD with or without hyperactivity, and
received at least one medication during 2005. Two sample pop-
ulations were examined: children of state employees (ASE) and
public school employees (PSE). 3.1% of children in both data-
bases (PSE = 499/16,102, ASE = 450/14,719) received at least
one stimulant. Mean age of children in the ASE (69.6%) was
11.2 years, ±3.6, and in the PSE (69.3% male) was 11.7 years,
±3.7. The most commonly prescribed stimulants were Adderall
(n = 220) and Concerta (n = 424). The dosage range for Adder-
all was 5 to 80 mg, and 18 to 144 mg for Concerta. There was
a positive correlation (p < 0.001) between age and Adderall
dosage (R = 0.36) and between age and Concerta dosage (R =
0.29). Dosages above the recommended maximum were seen in
7.7% of PSE and 4.9% of ASE children. CONCLUSION: Chil-
dren of ASE were equally likely as children of PSE to be treated
with stimulants for ADD, although there was a trend toward
higher dosages in the children of PSE.
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